Use of Regorafenib in Recurrent Epithelial Ovarian Cancer (Q66406077)
Jump to navigation
Jump to search
clinical trial
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Use of Regorafenib in Recurrent Epithelial Ovarian Cancer |
clinical trial |
Statements
An Open-Label, Single-Arm Phase 2 Clinical Trial Of Regorafenib in Patients With Multiply Recurrent Epithelial Ovarian Cancer (English)
0 references
3 February 2016
0 references
June 2019
0 references
43
0 references
21 year
0 references
99 year
0 references